Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 3215-3225

  Chen, Rui ^a   Brady, Erin ^a   McIntyre, Thomas M ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAOYL PHOSPHATIDYLCHOLINE; CHOLINE PHOSPHOLIPID; EDELFOSINE; ETHANOLAMINE PHOSPHOLIPID; FUNGAL PROTEIN; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEIN LEM3P; PROTEIN TMEM30A; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL ORGANELLE; CONTROLLED STUDY; FUNGAL GENE; HUMAN; HUMAN CELL; LEM3 GENE; MAMMAL CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE, TRANSFORMED; CHO CELLS; CHOLINE; CRICETINAE; CRICETULUS; DRUG RESISTANCE, NEOPLASM; HEP G2 CELLS; HL-60 CELLS; HUMANS; JURKAT CELLS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MUTANT CHIMERIC PROTEINS; PHOSPHOLIPIDS; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 79952755788     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002710     Document Type: Article

References (58)

1. van Blitterswijk, W. J., and M. Verheij. 2008. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr. Pharm. Des. 14: 2061-2074.
2. Gajate, C., A. M. Santos-Beneit, A. Macho, M. Lazaro, A. Hernandez-De Rojas, M. Modolell, E. Muñoz, and F. Mollinedo. 2000. Involvement of mitochondria and caspase-3 in ET-18-OCH(3)-induced apoptosis of human leukemic cells. Int. J. Cancer 86: 208-218. (Pubitemid 30180816)
3. Cuvillier, O., E. Mayhew, A. S. Janoff, and S. Spiegel. 1999. Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. Blood 94: 3583-3592. (Pubitemid 29536155)
4. Mollinedo, F., J. L. Fernández-Luna, C. Gajate, B. Mart?́n-Mart?́n, A. Benito, R. Mart?́nez-Dalmau, and M. Modolell. 1997. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL. Cancer Res. 57: 1320-1328. (Pubitemid 27152558)
5. Vrablic, A. S., C. D. Albright, C. N. Craciunescu, R. I. Salganik, and S. H. Zeisel. 2001. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac- glycero-3-phosphocholine in p53-defective hepatocytes. FASEB J. 15: 1739-1744.
6. Boggs, K. P., C. O. Rock, and S. Jackowski. 1995. Lysophosphatidylcholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the CTP:phosphocholine cytidylyltransferase step. J. Biol. Chem. 270: 7757-7764.
7. Zaremberg, V., C. Gajate, L. M. Cacharro, F. Mollinedo, and C. R. McMaster. 2005. Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition. J. Biol. Chem. 280: 38047-38058.
8. van der Luit, A. H., M. Budde, P. Ruurs, M. Verheij, and W. J. van Blitterswijk. 2002. Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis. J. Biol. Chem. 277: 39541-39547.
9. Gajate, C., E. Del Canto-Jañez, A. U. Acuña, F. Amat-Guerri, E. Geijo, A. M. Santos-Beneit, R. J. Veldman, and F. Mollinedo. 2004. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fasen-riched rafts in selective tumor cell apoptosis. J. Exp. Med. 200: 353-365.
10. Gajate, C., F. Gonzalez-Camacho, and F. Mollinedo. 2009. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS One 4: e5044.
11. Pomorski, T., J. C. Holthuis, A. Herrmann, and G. van Meer. 2004. Tracking down lipid flippases and their biological functions. J. Cell Sci. 117: 805-813. (Pubitemid 38386939)
12. Holthuis, J. C., and T. P. Levine. 2005. Lipid traffic: floppy drives and a super-highway. Nat. Rev. Mol. Cell Biol. 6: 209-220.
13. Devaux, P. F., I. López-Montero, and S. Bryde. 2006. Proteins involved in lipid translocation in eukaryotic cells. Chem. Phys. Lipids 141: 119-132.
14. Daleke, D. L. 2007. Phospholipid flippases. J. Biol. Chem. 282: 821-825.
15. Verhulst, P. M., L. M. van der Velden, V. Oorschot, E. E. van Faassen, J. Klumperman, R. H. Houwen, T. G. Pomorski, J. C. Holthuis, and L. W. Klomp. 2010. A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells. Hepatology 51: 2049-2060.
16. Hanson, P. K., L. Malone, J. L. Birchmore, and J. W. Nichols. 2003. Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine. J. Biol. Chem. 278: 36041-36050.
17. Kato, U., K. Emoto, C. Fredriksson, H. Nakamura, A. Ohta, T. Kobayashi, K. Murakami-Murofushi, T. Kobayashi, and M. Umeda. 2002. A novel membrane protein, Ros3p, is required for phospholipid translocation across the plasma membrane in Saccharomyces cerevisiae. J. Biol. Chem. 277: 37855-37862.
18. Riekhof, W. R., and D. R. Voelker. 2006. Uptake and utilization of lysophosphatidylethanolamine by Saccharomyces cerevisiae. J. Biol. Chem. 281: 36588-36596.
19. Elvington, S. M., F. Bu, and J. W. Nichols. 2005. Fluorescent, acyl chain-labeled phosphatidylcholine analogs reveal novel transport pathways across the plasma membrane of yeast. J. Biol. Chem. 280: 40957-40964.
20. Katoh, Y., and M. Katoh. 2004. Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico. Oncol. Rep. 12: 939-943.
21. Braquet, P., L. Touqui, T. Y. Shen, and B. B. Vargaftig. 1987. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39: 97-145.
22. Ishii, S., T. Nagase, and T. Shimizu. 2002. Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat. 68-69: 599-609. (Pubitemid 35247423)
23. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
24. Ihida, K., D. Predescu, R. P. Czekay, and G. E. Palade. 1999. Platelet activating factor receptor (PAF-R) is found in a large endosomal compartment in human umbilical vein endothelial cells. J. Cell Sci. 112: 285-295.
25. 2, PAF, and LPA1 receptors. Can. J. Physiol. Pharmacol. 84: 377-391.
26. Bazan, N. G., S. P. Squinto, P. Braquet, T. Panetta, and V. L. Marcheselli. 1991. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system. Lipids 26: 1236-1242.
27. Marrache, A. M., F. Gobeil, Jr., S. G. Bernier, J. Stankova, M. Rola-Pleszczynski, S. Choufani, G. Bkaily, A. Bourdeau, M. G. Sirois, A. Vazquez-Tello, et al. 2002. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol. 169: 6474-6481. (Pubitemid 36903498)
28. Melnikova, V. O., K. Balasubramanian, G. J. Villares, A. S. Dobroff, M. Zigler, H. Wang, F. Petersson, J. E. Price, A. Schroit, V. G. Prieto, et al. 2009. Cross-talk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J. Biol. Chem. 284: 28845-28855.
29. Bratton, D. L., J. M. Kailey, K. L. Clay, and P. M. Henson. 1991. A model for the extracellular release of PAF: the influence of plasma membrane phospholipid asymmetry. Biochim. Biophys. Acta 1062: 24-34.
30. Foulks, J. M., A. S. Weyrich, G. A. Zimmerman, and T. M. McIntyre. 2008. A yeast PAF acetylhydrolase ortholog suppresses oxidative death. Free Radic. Biol. Med. 45: 434-442.
31. Chen, R., A. E. Feldstein, and T. M. McIntyre. 2009. Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL. J. Biol. Chem. 284: 26297-26308.
32. Chen, R., L. Yang, and T. M. McIntyre. 2007. Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade. J. Biol. Chem. 282: 24842-24850.
33. Liu, J., R. Chen, G. K. Marathe, M. Febbraio, W. Zou, and T. M McIntyre. 2010. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis, by lipoprotein-associated phospholipase A2/PAF acetylhydrolase. Circ. Res. In press.
34. 2). Cardiovasc. Drugs Ther. 23: 73-83.
35. Podrez, E. A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, et al. 2002. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277: 38517-38523.
36. Yang, L., C. Latchoumycandane, M. R. McMullen, B. T. Pratt, R. Zhang, B. G. Papouchado, L. E. Nagy, A. E. Feldstein, and T. M. McIntyre. 2010. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. J. Biol. Chem. 285: 22211-22220.
37. Marathe, G. K., C. Johnson, S. D. Billings, M. D. Southall, Y. Pei, D. Spandau, R. C. Murphy, G. A. Zimmerman, T. M. McIntyre, and J. B. Travers. 2005. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J. Biol. Chem. 280: 35448-35457.
38. Lehr, H. A., A. S. Weyrich, R. K. Saetzler, A. Jurek, K. E. Arfors, G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre. 1997. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J. Clin. Invest. 99: 2358-2364.
39. Paulusma, C. C., D. E. Folmer, K. S. Ho-Mok, D. R. de Waart, P. M. Hilarius, A. J. Verhoeven, and R. P. Oude Elferink. 2008. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology 47: 268-278.
40. Quesada, E., J. Delgado, C. Gajate, F. Mollinedo, A. U. Acuña, and F. Amat-Guerri. 2004. Fluorescent phenylpolyene analogues of the ether phospholipid edelfosine for the selective labeling of cancer cells. J. Med. Chem. 47: 5333-5335.
41. Cabaner, C., C. Gajate, A. Macho, E. Muñoz, M. Modolell, and F. Mollinedo. 1999. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system. Br. J. Pharmacol. 127: 813-825.
42. Gajate, C., R. I. Fonteriz, C. Cabaner, G. Alvarez-Noves, Y. Alvarez-Rodriguez, M. Modolell, and F. Mollinedo. 2000. Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis. Int. J. Cancer 85: 674-682. (Pubitemid 30080481)
43. van der Velden, L. M., C. G. Wichers, A. E. van Breevoort, J. A. Coleman, R. S. Molday, R. Berger, L. W. Klomp, and S. F. van de Graaf. 2010. Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4 ATPases. J. Biol. Chem. 285: 40088-40096.
44. Saito, K., K. Fujimura-Kamada, N. Furuta, U. Kato, M. Umeda, and K. Tanaka. 2004. Cdc50p, a protein required for polarized growth, associates with the Drs2p P-type ATPase implicated in phospholipid translocation in Saccharomyces cerevisiae. Mol. Biol. Cell 15: 3418-3432.
45. Iwamoto, K., S. Kobayashi, R. Fukuda, M. Umeda, T. Kobayashi, and A. Ohta. 2004. Local exposure of phosphatidylethanolamine on the yeast plasma membrane is implicated in cell polarity. Genes Cells 9: 891-903. (Pubitemid 39369022)
46. Furuta, N., K. Fujimura-Kamada, K. Saito, T. Yamamoto, and K. Tanaka. 2007. Endocytic recycling in yeast is regulated by putative phospholipid translocases and the Ypt31p/32p-Rcy1p pathway. Mol. Biol. Cell 18: 295-312.
47. Saito, K., K. Fujimura-Kamada, H. Hanamatsu, U. Kato, M. Umeda, K. G. Kozminski, and K. Tanaka. 2007. Transbilayer phospholipid flipping regulates Cdc42p signaling during polarized cell growth via Rga GTPase-activating proteins. Dev. Cell 13: 743-751. (Pubitemid 350011986)
48. Zerp, S. F., S. R. Vink, G. A. Ruiter, P. Koolwijk, E. Peters, A. H. van der Luit, D. de Jong, M. Budde, H. Bartelink,W. J. van Blitterswijk, and M. Verheij. 2008. Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents. Anticancer Drugs 19: 65-75. (Pubitemid 350190969)
49. Alonso, M. T., C. Gajate, F. Mollinedo, M. Modolell, J. Alvarez, and J. García-Sancho. 1997. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis. Br. J. Pharmacol. 121: 1364-1368.
50. Pérez-Victoria, F. J., M. P. Sánchez-Cañete, S. Castanys, and F. Gamarro. 2006. Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites. J. Biol. Chem. 281: 23766-23775.
51. Sánchez-Cañete, M. P., L. Carvalho, F. J. Pérez-Victoria, F. Gamarro, and S. Castanys. 2009. Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug. Antimicrob. Agents Chemother. 53: 1305-1313.
52. Frey, B., R. Haupt, S. Alms, G. Holzmann, T. König, H. Kern, W. Kox, B. Rüstow, and M. Schlame. 2000. Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress. J. Lipid Res. 41: 1145-1153. (Pubitemid 30483020)
53. Frey, B., W. Johnen, R. Haupt, H. Kern, B. Rüstow, W. J. Kox, and M. Schlame. 2002. Bioactive oxidized lipids in the plasma of cardiac surgical intensive care patients. Shock 18: 14-17.
54. Zhang, Q., Y. Yao, R. L. Konger, A. L. Sinn, S. Cai, K. E. Pollok, and J. B. Travers. 2008. UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J. Invest. Dermatol. 128: 1780-1787.
55. Stremler, K. E., D. M. Stafforini, S. M. Prescott, and T. M. McIntyre. 1991. Human plasma platelet-activating factor acetylhydrolase: oxidatively fragmented phospholipids as substrates. J. Biol. Chem. 266: 11095-11103.
56. McIntyre, T. M., S. M. Prescott, and D. M. Stafforini. 2009. The emerging roles of PAF acetylhydrolase. J. Lipid Res. 50(Suppl.): S255-S259.
57. Marathe, G. K., G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre. 2002. Activation of vascular cells by PAF-like lipids in oxidized LDL. Vascul. Pharmacol. 38: 193-200.
58. 2, a marker of vascular inflammation and systemic vulnerability. Eur. Heart J. 30: 2829-2831.